PharmaRadar360

Entity and regulatory intelligence

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

46,976 stories, page 783 of 783

Advanced search

🇺🇸Jan 1, 1970Industrybilliontoone.comTier 1 · Company source

BillionToOne to Participate in the Wells Fargo 21st Annual Healthcare Conference - BillionToOne

BillionToOneOriginal source

🇺🇸Jan 1, 1970Industrybilliontoone.comTier 1 · Company source

BillionToOne Reports Second Quarter 2026 Results and Reiterates 2026 Revenue Guidance - BillionToOne

BillionToOneOriginal source

🇺🇸Jan 1, 1970Industrybilliontoone.comTier 1 · Company source

BillionToOne Launches Northstar Origin, a New Liquid Biopsy Test to Help Identify Tissue of Origin - BillionToOne

BillionToOneOriginal source

🇺🇸Jan 1, 1970Industrybilliontoone.comTier 1 · Company source

BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar - BillionToOne

BillionToOneOriginal source

🇺🇸Jan 1, 1970Researchascopubs.orgTier 2 · Direct publisher

The Boy Who Became a Tiger

ASCO JCO JournalOriginal source

🇺🇸Jan 1, 1970Industryargenx.comTier 1 · Company source

argenx Stories

argenx USOriginal source

🇫🇷Jan 1, 1970Regulatoryansm.sante.frTier 1 · Regulatory source

Rapports d'enquêtes de vigilance

French National Agency for Medicines and Health Products Safety (ANSM)Original source

🇫🇷Jan 1, 1970Regulatoryansm.sante.frTier 1 · Regulatory source

Publications scientifiques

French National Agency for Medicines and Health Products Safety (ANSM)Original source

🇫🇷Jan 1, 1970Regulatoryansm.sante.frTier 1 · Regulatory source

Protection des données à caractère personnel et politique de confidentialité

French National Agency for Medicines and Health Products Safety (ANSM)Original source

🇫🇷Jan 1, 1970Regulatoryansm.sante.frTier 1 · Regulatory source

Opérations réalisées par l'ANSM donnant lieu au paiement d'un droit

French National Agency for Medicines and Health Products Safety (ANSM)Original source

🇫🇷Jan 1, 1970Regulatoryansm.sante.frTier 1 · Regulatory source

- Consulter nos newsle t ters

French National Agency for Medicines and Health Products Safety (ANSM)Original source

🇫🇷Jan 1, 1970Regulatoryansm.sante.frTier 1 · Regulatory source

Mentions légales

French National Agency for Medicines and Health Products Safety (ANSM)Original source

🇫🇷Jan 1, 1970Regulatoryansm.sante.frTier 1 · Regulatory source

Les médicaments et moi

French National Agency for Medicines and Health Products Safety (ANSM)Original source

🇫🇷Jan 1, 1970Regulatoryansm.sante.frTier 1 · Regulatory source

Télécharger le texte de cette page au format PDF

French National Agency for Medicines and Health Products Safety (ANSM)Original source

🇫🇷Jan 1, 1970Regulatoryansm.sante.frTier 1 · Regulatory source

Gestion des cookies

French National Agency for Medicines and Health Products Safety (ANSM)Original source

🇫🇷Jan 1, 1970Regulatoryansm.sante.frTier 1 · Regulatory source

Documents administratifs mis à la disposition du public

French National Agency for Medicines and Health Products Safety (ANSM)Original source

🇫🇷Jan 1, 1970Regulatoryansm.sante.frTier 1 · Regulatory source

Autorisation de mise sur le marché pour les médicaments

French National Agency for Medicines and Health Products Safety (ANSM)Original source

🇫🇷Jan 1, 1970Regulatoryansm.sante.frTier 1 · Regulatory source

Tensions d’approvisionnement en Verkazia : Ikervis peut être dispensé temporairement aux enfants et adolescents

ANSM (France)Original source

🇫🇷Jan 1, 1970Regulatoryansm.sante.frTier 1 · Regulatory source

Tensions d’approvisionnement en Verkazia : ce collyre doit être réservé aux enfants et aux adolescents exclusivement

ANSM (France)Original source

🇫🇷Jan 1, 1970Regulatoryansm.sante.frTier 1 · Regulatory source

Rappel de deux lots de médicaments à base d’aflibercept destinés à l’injection dans l’œil en ophtalmologie

ANSM (France)Original source

🇫🇷Jan 1, 1970Regulatoryansm.sante.frTier 1 · Regulatory source

Quétiapine LP 50 mg : des mesures de gestion pour faire face aux nouvelles tensions

ANSM (France)Original source

🇫🇷Jan 1, 1970Regulatoryansm.sante.frTier 1 · Regulatory source

Point de situation sur les tensions en furosémide 20 mg et 40 mg comprimés

ANSM (France)Original source

🇫🇷Jan 1, 1970Regulatoryansm.sante.frTier 1 · Regulatory source

Point de situation sur les tensions en fluoxétine 20 mg

ANSM (France)Original source

🇫🇷Jan 1, 1970Regulatoryansm.sante.frTier 1 · Regulatory source

Modification des conditions de prescription d’inhibiteurs de Janus kinase (JAKi) indiqués dans le traitement de maladies inflammatoires chroniques

ANSM (France)Original source

🇫🇷Jan 1, 1970Regulatoryansm.sante.frTier 1 · Regulatory source

L'ANSM obtient le score de 98/100 pour son index de l’égalité professionnelle 2025

ANSM (France)Original source

🇫🇷Jan 1, 1970Regulatoryansm.sante.frTier 1 · Regulatory source

L’ANSM active le plan 2026-2027 de suivi des médicaments et des dispositifs médicaux de l’hiver

ANSM (France)Original source

🇫🇷Jan 1, 1970Regulatoryansm.sante.frTier 1 · Regulatory source

L’ANSM accueille l'IncreaseNET x EU Innovation Network 2026 Innovation & Competitiveness Summit

ANSM (France)Original source

🇫🇷Jan 1, 1970Regulatoryansm.sante.frTier 1 · Regulatory source

Alepsal : remise à disposition de tous les dosages

ANSM (France)Original source

🇫🇷Jan 1, 1970Regulatoryansm.sante.frTier 1 · Regulatory source

Grippe, Covid-19, bronchiolite : se protéger contre les infections respiratoires de l’hiver

ANSM (France)Original source

🇫🇷Jan 1, 1970Regulatoryansm.sante.frTier 1 · Regulatory source

Duloxétine : l’ANSM demande aux laboratoires de renforcer leurs approvisionnements

ANSM (France)Original source

🇫🇷Jan 1, 1970Regulatoryansm.sante.frTier 1 · Regulatory source

Actualités

ANSM (France)Original source

🇫🇷Jan 1, 1970Regulatoryansm.sante.frTier 1 · Regulatory source

3ᵉ rapport de pharmacovigilance sur les aGLP-1 : persistance du mésusage associé à des complications graves et mise en évidence du risque d’interactions médicamenteuses

ANSM (France)Original source

🇺🇸Jan 1, 1970Industryalexion.comTier 1 · Company source

Understanding treatment impact and addressing disparities in rare disease care | Alexion Global Site

Alexion (AstraZeneca)Original source

🇺🇸Jan 1, 1970Industryalexion.comTier 1 · Company source

Tina’s Big Trip | Alexion Global Site

Alexion (AstraZeneca)Original source

🇺🇸Jan 1, 1970Industryalexion.comTier 1 · Company source

Following the Science: The Evolution of Complement Inhibition in Rare Disease | Alexion Global Site

Alexion (AstraZeneca)Original source

🇺🇸Jan 1, 1970Industryalexion.comTier 1 · Company source

AI to shorten the rare disease diagnosis | Alexion Global Site

Alexion (AstraZeneca)Original source

🇺🇸Jan 1, 1970Industryalexion.comTier 1 · Company source

Pioneering new possibilities for the rare disease community

Alexion (AstraZeneca)Original source

🇺🇸Jan 1, 1970Industryalexion.comTier 1 · Company source

Advancing Rare Disease Research Through Patient-Centric Trial Design: Hear from Alexion R&D leader Gianluca Pirozzi | Alexion Global Site

Alexion (AstraZeneca)Original source

🇺🇸Jan 1, 1970Industryalexion.comTier 1 · Company source

Genomic Innovation to Support Newborn Screening of Rare Diseases | Alexion Global

Alexion (AstraZeneca)Original source

🇺🇸Jan 1, 1970Industryalexion.comTier 1 · Company source

How can data, healthcare access and global collaboration advance health equity in rare diseases? | Alexion Global Site

Alexion (AstraZeneca)Original source

🇺🇸Jan 1, 1970Industryalexion.comTier 1 · Company source

Keeping Patients at the Forefront of Rare Disease Innovation: Hear from Alexion R&D leader Seng H. Cheng | Alexion Global Site

Alexion (AstraZeneca)Original source

🇨🇭Jan 1, 1970Researchnews.uzh.chTier 2 · Direct publisher

In Conversation with the World

University of Zurich - Med NewsOriginal source

🇨🇭Jan 1, 1970Researchnews.uzh.chTier 2 · Direct publisher

How to Switch Off and Recharge

University of Zurich - Med NewsOriginal source

🇨🇭Jan 1, 1970Researchnews.uzh.chTier 2 · Direct publisher

Kunsthaus and UZH Join Forces to Step Up Provenance Research

University of Zurich - Med NewsOriginal source

🇨🇭Jan 1, 1970Researchnews.uzh.chTier 2 · Direct publisher

“I missed China’s speed”

University of Zurich - Med NewsOriginal source

🇨🇭Jan 1, 1970Researchnews.uzh.chTier 2 · Direct publisher

“Trust is not a moral luxury”

University of Zurich - Med NewsOriginal source

🌍Jan 1, 1970Regulatoryemro.who.intTier 1 · Regulatory source

WHO scales up Bundibugyo virus disease readiness in the Eastern Mediterranean Region amid conflict and displacement

WHO EMROOriginal source

🌍Jan 1, 1970Regulatoryemro.who.intTier 1 · Regulatory source

WHO Regional Office for the Eastern Mediterranean and Rotary reaffirm commitment to ending polio at World Polio Day events in Cairo

WHO EMROOriginal source

🌍Jan 1, 1970Regulatoryemro.who.intTier 1 · Regulatory source

WHO Eastern Mediterranean countries adopt resolutions to strengthen financial protection and accelerate disease elimination

WHO EMROOriginal source

🌍Jan 1, 1970Regulatoryemro.who.intTier 1 · Regulatory source

WHO and Gulf CDC strengthen their strategic partnership to advance health security across the Gulf

WHO EMROOriginal source

🌍Jan 1, 1970Regulatoryemro.who.intTier 1 · Regulatory source

Strengthening integrated surveillance across WHO’s Eastern Mediterranean Region

WHO EMROOriginal source

🌍Jan 1, 1970Regulatoryemro.who.intTier 1 · Regulatory source

Opening Remarks by Dr Adham Ismail, officer in charge WHO Eastern Mediterranean Region at the Launch of the First Digital Platform for Health Research Prioritization in the Eastern Mediterranean Region

WHO EMROOriginal source

🌍Jan 1, 1970Regulatoryemro.who.intTier 1 · Regulatory source

Fuel and medical supply shortages threaten lifesaving health services in Yemen’s Taiz as access remains severely restricted

WHO EMROOriginal source

🌍Jan 1, 1970Regulatoryemro.who.intTier 1 · Regulatory source

Eastern Mediterranean Region renews its commitment to a polio-free world

WHO EMROOriginal source

🌍Jan 1, 1970Regulatoryemro.who.intTier 1 · Regulatory source

Closing Remarks by Dr Adham Ismail, officer in charge WHO Eastern Mediterranean: Progress report on health issues facing populations affected by disasters and emergencies, including implementation of the International Health Regulations (2005)

WHO EMROOriginal source

🌍Jan 1, 1970Regulatoryemro.who.intTier 1 · Regulatory source

Closing Remarks by Dr Adham Ismail, officer in charge WHO Eastern Mediterranean at the 73rd Regional Committee

WHO EMROOriginal source